Peng Ma

683 total citations
29 papers, 525 citations indexed

About

Peng Ma is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Peng Ma has authored 29 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Peng Ma's work include MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Peng Ma is often cited by papers focused on MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Peng Ma collaborates with scholars based in China, United States and Sweden. Peng Ma's co-authors include Erik Lundgren, Qin‐Sheng Mao, Hansong Deng, Ying Feng, Yilin Hu, Jing Ke, Wanjiang Xue, Jina Yun, Jinxia Hu and Rutong Yu and has published in prestigious journals such as PLoS ONE, Molecular Biology of the Cell and Experimental Cell Research.

In The Last Decade

Peng Ma

27 papers receiving 518 citations

Peers

Peng Ma
Comparison fields: 5 of 75
  • Molecular Biology 230
  • Oncology 174
  • Cancer Research 123
  • Pathology and Forensic Medicine 93
  • Physiology 79
Replace Elisabeth Martin with:
Elisabeth Martin France
Hironori Matsuura Japan
Karin Álvarez Chile
Patrycja Przygodzka Poland
Irene Kamileri Greece
Mo Chen China
Hiroki Mukai Japan
Vivek Reddy Palicharla United States
Bo Ling China
Elisabeth Martin France View profile →
Citations per field, relative to Peng Ma
Peng Ma · 1×
Citations per year, relative to Peng Ma
Peng Ma · 1×

Countries citing papers authored by Peng Ma

Since Specialization
Citations

This map shows the geographic impact of Peng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Ma more than expected).

Fields of papers citing papers by Peng Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Ma. The network helps show where Peng Ma may publish in the future.

Co-authorship network of co-authors of Peng Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Ma. A scholar is included among the top collaborators of Peng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Ma. Peng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 0
4 5
5 8
6 20
7 8
8 18
9 14
10 18
11 12
12 7
13 24
14 7
15 26
16 24
17 16
18 16
19 46
20
Study on antineoplastic activity and blood cell haemolysis test to saponin
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026